PROM1 and liver cancer: For example, in brain, skin, pancreatic, and liver cancer, the CD133+ CSC populations produce higher levels of proangiogenic factors, such as vascular endothelial growth factor (VEGF) and SDF-1, recruit more endothelial cells, and stimulate more tube formation compared with their differentiated CD133− counterparts [29–31].